journal1 ›› 2016, Vol. 24 ›› Issue (1): 58-60.doi: 10.12016/j.issn.2096-1456.2016.01.014

Special Issue: 11

• Review Articles • Previous Articles    


  • Received:2015-08-12 Online:2016-01-20 Published:2016-01-20

CLC Number: 

  • R739.8
[1] Madsen P, Rasmussen HH, Leffers H, et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein “psoriasin” that is highly up-regulated in psoriatic skin[J]. Invest Dermatol, 1991,97(4):701-712.
[2] Matthew B, Saul R, Julien B. Conjunctival transcriptome in scarring trachoma[J]. Infect Immun, 2011,79(1):499-511.
[3] 徐磊,曾维惠,郑焱.Psoriasin在亚急性和慢性湿疹中的表达[J].中国皮肤性病学杂志,2012,26(5):386-388.
[4] 孙丽梅,王健,田连胜,等.乳腺癌中S100A7 与AKT 的表达及意义[J].临床与实验病理学杂志,2012,28(9):963-966.
[5] 张颢,刘丹慧,孙锁柱,等.钙结合蛋白S100A7在肺癌中的选择性表达[J].中国肺癌杂志,2009,12(1):54-58.
[6] 陈晓萍.S100A4、S100A7、S100A11在非小细胞肺癌中的表达及其临床意义[D].苏州:苏州大学,2012.
[7] 邱乐宏,马洪.口腔鳞癌组织蛋白差异表达的蛋白组学测定[J].口腔医学,2011,31(8):453-455.
[8] Marco K, Holger S, Rafael H, et al. Psoriasin(S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features[J].Oral Oncology, 2009,45(8):731-736.
[9] Bernd A, Jrg S ,Peter L, et al. Differential expression of CRABP Ⅱ,psoriasin and cytokeratin 1 mRNA in human skin diseases[J].Arch Dermatol Res, 1996,288(8):426-430.
[10] Arby A, Leopold E, Michael M, et al. Flagellin is the principal inducer of the antimicrobial peptide S100A7c (psoriasin) in human epidermal keratinocytes exposed to Escherichia coli[J]. FASEB J, 2008,22(7):2168-2176.
[11] Hoffmann HJ, Olsen E, Etzerodt M, et al. Psoriasin binds calcium and is upregulated by calcium to levels that resemble those observed in normal skin[J]. J Invest Dermatol, 1994,103(3):370-375.
[12] Carlsson H, Yhr M, Petersson S, et al. Psoriasin (S100A7) and Calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants[J]. Cancer Biol Ther, 2005,4(9):998-1005.
[13] Glser R, Navid F, Schuller W, et al. UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo[J]. J Allergy Clin Immunol, 2009,123(5):1117-1123.
[14] Yoshio H, Tollin M, Gudmundsson GH, et al. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense[J]. Pediatr Res, 2003,53(2):211-216.
[15] Glser R, Harder J, Lange H, et al. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection[J]. Nat Immunol, 2005,6(1):57-64.
[16] Zheng Y, Niyonsaba F, Ushio H, et al. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation[J]. Immunology, 2008,124(3):357-367.
[17] Glser R, Mager-Hoffert U, Harder J, et al. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption[J]. J Invest Dermatol, 2009,129(3):641-649.
[18] Meyer JE, Harder J, Sipos B,et al.Psoriasin(S100A7)is a principal antimicrobial peptide of the human tongue[J]. Mucosal Immunol, 2008,1(3):239-243.
[19] Anne K, Camilla R, Malin J, et al. Diminished levels of nasal S100A7 (psoriasin) in seasonal allergic rhinitis: an effect mediated by Th2 cytokines[J]. Respir Res, 2012,13(1):2-11.
[20] Wolr R, Howard OM, Dong HF, et al. Chemotactic activity of s100A7 (psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15[J]. J Immunol, 2008,181(2):1499-1506.
[21] Nicolini A, Carpi A, Rossi G. Cytokines in breast cancer[J]. Cytokine Growth Factor Rev, 2006,17(5):325-337.
[22] Ruse M, Broome AM, Eckert RL.S100A7 (psoriasin) interacts with epidermal fatty acid binding protein and localizes in focal adhesion-like structures in cultured keratinocytes[J]. J Invest Dermatol, 2003,121(1):132-141.
[23] Gerry H, Isabelle M, Eric A, et al. Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes[J]. Biochem J, 1999,339(2):419-427.
[24] Fabian G, Maria G, Thomas S, et al. Expression and regulation of antimicrobial peptide psoriasin (S100A7) at the ocular surface and in the lacrimal apparatus[J]. Invest Ophthalmol Vis Sci, 2011,52(7):4914-4922.
[25] Ann-Marie B, David R, Richard E. S100 protein subcellular localization during epidermal differentiation and psoriasis[J]. J Histochem Cytochem, 2003,51(5):675-685.
[26] Tripathi SC, Matta A, Kaur J, et al. Nuclear S100A7 is associated with poor prognosis in head and neck cancer[J]. PLoS One, 2010,5(8):e11939.
[27] 赖史胜,万志荔.S100A7蛋白在头颈鳞状细胞癌中的表达与意义[J].临床耳鼻咽喉头颈外科杂志,2014,28(18):1376-1379.
[28] Ethan DE, Salem A, Linda S, et al.S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast[J]. Breast Cancer Res, 2004,6(4):308-315.
[29] Zhou G, Xie TX, Zhao M, et al. Reciprocal negative regulation between S100A7/psoriasin and b-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity[J]. Oncogene, 2008,27(25):3527-3538.
[30] Qi Z, Li T, Kong F, et al. The characteristics and function of S100A7 induction in squamous cell carcinoma: heterogeneity, promotion of cell proliferation and suppression of differentiation[J]. PLoS ONE, 2015,10(6):e0128887.
[31] Li T, Qi Z, Kong F, et al. S100A7 acts as a dual regulator in promoting proliferation and suppressing squamous differentiation through GATA-3/caspase-14 pathway in A431 cells[J]. Exp Dermatol, 2015,24(5):342-348.
[32] Kathleen CL, Richard LE. S100A7 (psoriasin)-mechanism of antibacterial action in wounds[J]. J Invest Dermatol, 2007,127(4):945-957.
[33] Emman S, Jenny V, Maria C, et al. Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation[J]. Breast Cancer Res Treat, 2012,134(1):71-80.
[34] Ian K, Annette M, Hanna C, et al. A putative role for psoriasin in breast tumor progression[J]. Cancer Res, 2005,65(24):11326-11334.
[35] 姜丽,赵文明,孙吉瑞,等.S100A7在基底细胞样乳腺癌中的表达及临床意义[J].国际肿瘤学杂志,2014,41(3):229-232.
[36] Skliris GP, Lewis A, Emberley E, et al. Estrogen receptor-β regulates psoriasin(S100A7)in human breast cancer[J]. Breast Cancer Res Treat, 2007,104(1):75-85.
[37] West NR, Watson PH. Exploring and exploiting the protein S100A7 as a new target for breast cancer therapy[J].Oncogene, 2010,29(14):2083-2092.
[38] Nasser NW, Qamri Z, Deol YS, et al. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways[J]. Cancer Res, 2012,72(3):604-615.
[39] Sneh A, Deol YS, Ganju A, et al. Differential role of psoriasin (S100A7) in estrogen receptor-α positive and negative breast cancer cells occur through actin remodeling[J]. Breast Cancer Res Treat, 2013,138(3):727-739.
[40] Liu H, Wang L, Wang X, et al. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling[J]. World J Surg Oncol, 2013,11(1):93.
[41] Yadwinder SD, Mohd WN, Lianbo Yu, et al. Tumor suppressive effects of psoriasin (S100A7) are mediated through β-catenin/TCF4 pathway in estrogen receptor positive breast cancer cells[J]. J Bio Chem, 2011,286(52):44845-44854.
[42] Giaretti W, Maffei M, Pentenero M, et al. Genomic aberrations in normal apperaing mucosa fields distal from oral potentially malignant lesions[J]. Cell Oncol, 2012,35(1):43-52.
[43] Jatinder K, Ajay M, Ipshita K, et al. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer, 2014,134(6):1379-1388.
[44] Hideaki F, Tamotsu K, Ieyoshi K, et al. Transcription promoter activity of the human S100A7 gene in oral squamous cell carcinoma cell lines[J]. Biochim Biophys Acta, 2006,1759(3/4):171-176.
[45] 陈谦明.口腔黏膜病学[M].4版.北京:人民卫生出版社,2012:127.
[46] Yuka H, Mika B, Masatoshi K, et al. Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1α[J]. Arch Oral Biol, 2011,56(8):761-767.
[47] 刘健,凌天牖,傅润英,等.槟榔碱对HaCaT细胞增殖活性及S100A7 mRNA表达的影响[J].口腔医学研究,2010,26(5):664-667.
[48] Foell D, Frosch M, Sorq C, et al. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation[J]. Clin Chim Acta, 2004,344(1/2):37-51.
[1] LI Ming,NAN Xinrong,YUAN Zhenying,TANG Zhangui. Accuracy analysis of MRI in the depth of invasion assessment of tongue squamous cell carcinoma [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(5): 322-327.
[2] WEI Zhuo,GUO Jun,HUANG Yi,FEI Wei,LUO Jianfeng. Clinical effect of anterolateral thigh flap repair on postoperative defects in oral malignant tumors [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(5): 328-333.
[3] WANG Liye,GAO Ying,TIAN Chun. Identification of potential genetic markers in prognosis of oral squamous cell carcinoma patients by bioinformatic analysis [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2021, 29(1): 27-33.
[4] QIN Lingling,CHEN Ying,SU Miao,ZHANG Hanbin. Prognostic impacts of marital status on patients with buccal mucosa squamous cell carcinoma [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(11): 718-722.
[5] CHEN Shuwei,YANG Ankui,ZHANG Quan,CHEN Wenkuan,LI Hao,LI Qiuli,CHEN Yanfeng,CHEN Weichao,YANG Zhongyuan,ZHANG Xing,SONG Ming. Analysis of clinicopathological characteristics and survival of 1 915 oral cavity squamous cell carcinoma patients: 24-year experience from a single institution [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(8): 487-493.
[6] LI Ming,YAN Xingquan,NAN Xinrong. Clinical report of cheek mass after injection and filling of hyaluronic acid in the cheek [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(8): 510-513.
[7] TAO Qian,YANG Yaocheng. Logic and clinical significance of the new WHO classification of ameloblastoma in 2017 [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(7): 416-420.
[8] LIU Enyan,HE Bing,LI Mingyun. Research progress on epigallocatechin-3-gallate in the prevention and treatment of oral cancer [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(7): 468-471.
[9] WANG Zhangsong,XIE Shule,ZHANG Hanqing,FANG Zezhen,LI Qunxing,FAN Song,LI Jinsong. Clinical and pathological analysis of 2 456 cases of salivary gland tumor [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(5): 298-302.
[10] LI Xiaodong,MENG Jian. Application progress of recombinant human endostatin in the treatment of head and neck cancer [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(4): 267-272.
[11] ZHANG Yu,JI Tong. Application of Indocyanine green in visual treatment of oral cancer [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2020, 28(2): 118-122.
[12] ZHENG Jiawei,ZHAO Zeliang. Progress in the genetics research of infantile hemangioma and vascular malformations [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2019, 27(12): 749-756.
[13] ZENG Sujuan,PENG Bo,CHENG Weidong,WEI Dongfeng,HUANG Wenyan,LI Yunyang,ZHAO Wanghong. Experimental study on the effect of hedysarum polybotys saccharides and selenizated hedysarum polybotys saccharides on oral squamous cancer cells in vitro [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2019, 27(12): 757-762.
[14] BUHAILIQIGULI Maimaitituersun,PATIGULI Wusiman,ADILI Moming. Peripheral primitive neuroectodermal tumor of the mandible: a case report and literature review [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2019, 27(12): 784-787.
[15] HUANG Lihuan,JIANG Yingtong,OUYANG Kexiong,WU Lihong,YANG Xuechao. Research progress on the role and mechanism of miR-155 in the development of oral squamous cell carcinoma [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2019, 27(12): 809-812.
Full text



[1] ZHU Song-song, HU Jing. The application of distraction osteogenesis in the temporomandibular joint ankylosis and secondary dentofacial deformities[J]. journal1, 2016, 24(1): 6 -10 .
[2] XU Jing. The influence of the impacted mandibular third molar extraction on the distal periodontal tissue of the mandibular second molar[J]. journal1, 2016, 24(1): 11 -14 .
[3] ZHONG Jiang-long, PAN Ji-yang, CHEN Wei-liang. The evaluation of Eagle syndrome treatment by surgery combined with antidepressant therapy[J]. journal1, 2016, 24(1): 26 -28 .
[4] CHEN Xi, SUN Qin-zhou. The study of colorimetric board of porcelain fused to metal restoration for moderate to severe dental fluorosis[J]. journal1, 2016, 24(1): 33 -36 .
[5] OUYANG Ke-xiong1, LIANG Jun, ZOU Rui, LI Zhi-qiang, BAI Zhi-bao, PIAO Zheng-guo, ZHAO Jian-Jiang.. Ion Torrent RNA-Seq detection and analysis of the long non-coding RNA in tongue squamous cell carcinoma[J]. journal1, 2016, 24(1): 15 -19 .
[6] YU Pei, XUE Jing, ZHANG Xiao-wei, ZHENG Cang-shang. The influence of the roughness of zirconia ceramic surface on microbial attachment[J]. journal1, 2016, 24(1): 20 -25 .
[7] LIU Fang. Clinical assessment of two fissure sealant techniques in children’s dental caries prevention[J]. journal1, 2016, 24(1): 44 -45 .
[8] . [J]. journal1, 2016, 24(1): 49 -52 .
[9] LU Jian-rong, BAN Hua-jie, WANG Dai-you, ZHOU Hui-hui, LONG Ru, QIN Shu-hua. Clinical observation of sternocleidomastoid muscle flaps combined with artificial biological membrane reparing the defects after parotidectomy[J]. journal1, 2016, 24(1): 29 -32 .
[10] LI Bin, HE Xiao-ning, GAO Yuan, HU Yu-ping. Clinical analysis of pain after two kinds of apical stop preparation[J]. journal1, 2016, 24(1): 40 -43 .
This work is licensed under a Creative Commons Attribution 3.0 License.